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Application of neutralizing anti-hemagglutinin antibodies to mouse neuroblastoma cells (NS20Y/MS) 
persistently infected with measles virus (MV) Ieads to a significant reduction of viral structural proteins within 
6 days. While the transcriptional gradient for MV-specific mRNAs remained unall'ected upon antibody 
treatment, the total amount of MV -specific transcripts dropped by 80% after 24 h. The expression of genomic 
RNA was afl'ected similarly, with slightly slower time kinetics. Both transcription and expression of the viral 
structural proteins could be completely reactivated when viral antibodies were removed from the tissue culture. 
The same findings could be obtained in rat glioma cells persistently infected with subacute sclerosing 
panencephalitis virus (C6/SSPE) but not in cells of nonneural origin. The data indicate that antibody-induced 
antigenic modulation afl'ects the early stages of viral transcription within a few hours after the addition of 
antibodies and Ieads to an almost complete repression of viral gene expression in cells of neural origin. 
Measles virus (MV) is the etiological agent of subacute 
sclerosing panencephalitis (SSPE) and measles inclusion 
body encephalitis, which develop after incubation periods of 
months to years on the basis of a persistent infection in 
neurons and ganglion cells (41). Intense molecular analyses 
performed on autopsy brain material revealed that MV 
persistence is characterized by alterations of viral gene 
expression at the Ievels of transcription and translation (2, 
6. 7 .8, 13). The mechanisms governing the establishment and 
maintenance of a persistent MV infection in brain cells are 
stilllargely unknown. 
Recently, it has been shown that the transcriptional down 
regulation of MV-specific monocistronic mRNAs 3' of the N 
gene in brain material of patients with SSPE seems to 
represent the action of cell-type-specific factors rather than a 
consequence of viral persistence (39, 40). Furthermore, a 
cellular double-stranded RNA-specific unwinding-modifica-
tion activity has been suggested to act on MV gene tran-
scripts in brain cells, leading to hypermutation events that in 
turn could Iead to down regulation of MV gene expression 
(5, 14, 34). In addition, MV transcription may also be 
infiuenced by the state of differentiation of the infected cells 
(25, 37, 44). 
Besides intracellular mechanisms, virus-neutralizing anti-
hodies are also effective in regulating MV gene expression as 
described in tissue cultures as weil as in in vivo experiments 
( 4, 17, 18, 24, 32, 38). Antibody-dependent down regulation 
of intracellular MV -specific structural proteins has been 
observed after prolonged passages in rat glioma C6/SSPE 
and mouse neuroblastoma NS20Y /MS cells ( 4, 32) but not in 
cells of nonneural origin ( 4, 38). In vivo, passive transfer of 
virus-neutralizing antibodies Ieads to a prolongation of ex-
perimentally induced infections of the central nervous sys-
tem in rodents accompanied by a highly restricted expres-
sion of viral structural proteins and mRNAs (24, 33). 
In order to investigate the early effects of antibody-
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dependent antigenic modulation on MV gene expression in 
cells of neural origin, we analyzed viral replication and 
transcription during the first few days after the application 
of virus-neutralizing antibodies to mouse neuroblastoma 
NS20Y/MS and rat glioma C6/SSPE cells. 
The data reveal a significant reduction of the intracellular 
viral structural proteins after antibody treatment as weil as a 
strong decrease in virus-specific transcription to 20% of the 
original expression frequency within 24 h. Since transcrip-
tion of genomic RNA was equally affected and the slope of 
the gradient of the monocistronic mRNAs was similar tothat 
of untreated cells, the down regulation of viral transcription 
in our system is not specific for individual RNAs but rather 
refiects a general inhibition of MV transcription during 
persistent infection. 
MATERIALSAND MEmODS 
Cell lines and viruses. The Cl300 neuroblastoma clone 
NS20Y of the NJ mouse strain was used. The establishment 
of MV persistently infected (PI) NS20Y cells is described in 
detail elsewhere (32). For our experiments, subclone 
NS20Y /MS was used, which did not produce infectious virus 
at any temperature. In addition, rat glioma C6 cells PI with 
SSPE LEC virus (19), human Jung fibroblast cells Car Lu PI 
with the Edmonston strain of MV (28), and Vero cells were 
used. MV/CAM was propagated in Vero cells (22). For the 
lytic infection, Vero cells were infected at a multiplicity of 
infection of 0.5 PFU per cell and were harvested after 72 h. 
Aßtibodies and antibody treatment. Polyclonal anti-MV 
hyperimmune serum was obtained after immunization of 
rabbits with purified MV Edmonston grown on Vero cells 
(21). The preparation and characterization of monoclonal 
antibodies against MV N and H proteins were described 
elsewhere (8, 10, 29). For treatment with antibodies, the 
medium of semiconfluent cultures was replaced with fresh 
medium containing anti-MVhyperimmune serum (sufficient 
to neutralize 104 PFU of MV) or, when indicated, a mixture 
of neutralizing anti-H antiborlies (L77, NC 32, and K83) as a 
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stock solution with a titer in the hemagglutinin inhibition 
(HI) assay of 16,000 HI U/ml; the mixturewas prediluted in 
minimum essential medium before application on tissue 
culiure cells ( 40 HI U/ml). For the time kinetics, antibody-
treated or untreated cells were harvested at the times indi-
cated after antibody treatment. After 3 days, the cells were 
split and fresh antiborlies were applied to the medium. For 
reactivation, antiborlies were removed from the culture 
supernatant and cells were harvested 144 h, 216 h, and 14 
days later. 
Fluorescence analysis. The percentage of MV -positive cells 
in the cultures was determined by using either indirect 
immunoftuorescence or ftuorescence-activated cell sorter 
(FACS) analysis. After extensive washing, cells were fixed 
for FACS analysis in 10% paraformaldehyde in phosphate-
buffered saline (PBS) for 15 min followed by two rinses in 
PBS and subsequent permeabilization in 0.25% Triton X-100 
for 20 min at room temperature. After a further rinse in PBS, 
the primary antibody ( either monoclonal antiborlies directed 
against N, M, F, or H or a polyclonal measles serum; each as 
a dilution of 1:50) was applied for 3 h at room temperature. 
Cells were rinsed in PBS and incubated with the second 
antibody (goat anti-mouse or goat anti-human immunoglob-
ulin, respectively, diluted 1:50 in PBS containing 5% new-
born rat serum) at 4°C for 150 min. After a final rinse in PBS, 
cells were analyzed by F ACScan. 
Preparation of ceU extracts and Western immunoblot anal-
ysis. For protein analysis, cells were washed with PBS, 
resuspended, and lysed in ice-cold buffer containing 50 mM 
Tris IiCl (pH 7.5), 150 mM NaCl, 0.05% Nonidet P-40, 0.1% 
SDS, and 0.25% sodium deoxycholate. Extracts were clari-
fied by centrifugation for 30 min at 4°C at 12,000 x g. After 
determination of the protein concentration, samples contain-
ing 150 .,._g of protein were separated on 10% polyacrylamide 
gels and transferred to nitrocellulose filters. After being 
blocked for 1 h in 10% milk (1.5% fat) in PBS at 37°C, the 
nitrocellulose filters were incubated overnight at 4°C with 
MV antibodies. Filters were washed three times with PBS at 
room temperature and incubated with peroxidase-conju-
gated anti-rabbit immunoglobulin in 1% milk for 1 h. After 
being washed as indicated above, filters were developed with 
4-chloronaphthol (0.3 mg!ml) and H20 2• 
RNA extraction and quantitative Northem (RNA) blot 
analyses. RNA extraction, selection of poly(A)+ RNA, and 
quantitative Northern blot analyses were performed as de-
scribed before (39). Briefty, after cell Iysis in 4 M guanidin-
ium isothiocyanate buffer, the RNA was separated by ce-
sium chloride centrifugation and used either directly as total 
RNA or enriched for poly(A)+ RNA by a single selection 
over an oligo(dT) column. Each 2 .,._g of poly(A)+ RNA 
together with a mixture of synthetic standard RNA tran-
scripts (11, 12) was separated on 1.5% formaldehyde-con-
taining a~arose gels, blotted onto nitrocellulose, and hybrid-
ized to [ 2P]CfP-labelled single-stranded RNA transcripts 
specific for each individual MV structural gene except L. 
After exposition, signals specific for the monocistronic MV-
specific and standard RNA transcripts were excised and the 
radioactivity retained was determined by scintillation count-
ing. Rat GAPDH-specific cDNA (16) and the MV N-specific 
851-bp cDNA (12) were used as gel-purified fragments for 
random priming in the presence of (32P]dCfP, following the 
manufacturer's protocol (Boehringer GmbH, Mannheim, 
Germany). 
In vitro translation. Each 1 .,._g of poly(A) + -enriched RNA 
was translated in vitro in the presence of 30 .,._ci of [35S]me-
thionine in rabbit reticulocyte lysate for 90 min, following 
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the manufacturer's protocol (Promega). MV-specific trans-
lation products were immunoprecipitated by using a poly-
clonal rabbit anti-MV hyperimmune serum and subsequently 
were separated by 10% polyacrylamide gel electrophoresis 
as described previously (39). 
RESULTS 
Characterization of untreated NS20Y/MS and C6/SSPE 
cells PI with MV. By immunoftuorescence with a polyclonal 
anti-MV hyperimmune serum, 100% of C6/SSPE cells exhib-
ited positive staining and 35 to 40% of NS20Y /MS cells 
exhibited positive staining. Using monoclonal antibodies, we 
could show that in both celllines, every infected cell stained 
positive for the individual structural proteins N, M, F, and H 
(not shown). Transcription of MV -specific monocistronic 
mRNAs was analyzed by quantitative Northem blot exper-
iments using poly(A)+ -enriched RNA from NS20Y/MS, C6/ 
SSPE, and lytically infected Vero cells (Fig. 1). Compared 
with the lytic control in Vero cells (Fig. 1a), the transcrip-
tional activity in NS20Y/MS cells was reduced to about 5%, 
as determined by measuring the expression of the N mRNA-
specific transcript per 10 pg of RNA (Fig. 1b). The frequency 
of expression of the monocistronic MV -specific transcripts 
decreased markedly along the gene order, with the P mRNA 
being expressed to 52.4% of the N mRNA, the M mRNA 
being expressed to 26%, the F mRNA being expressed to 
10%, and the H mRNA being expressed to 5.5% as shown 
for NS20Y/MS cells (Table 1). In addition to the quantitative 
alterations, the M-specific mRNA appeared as a double band 
in these cells (Fig. lb, lane 3). 
This particular down regulation of transcripts specific for 
the envelope genes was described previously in brain mate-
rial of patients with SSPE and experimentally MV -infected 
rats (indicated for comparison in Fig. ld) and could also be 
found in C6/SSPE cells (Fig. 1c). 
Ell'ects of antibody treatment on the synthesis of MV 
structural proteins. To investigate the effect of anti-MV 
treatment on the synthesis of MV structural proteins that 
normally accumulate to high quantities in PI NS20Y/MS 
cells, a polyclonal antiserum was applied for different time 
periods. Cells were harvested at different time intervals as 
indicated and stained for the presence of MV structural 
proteins N, M, F, and H (Table 2). Whereas the percentage 
of positive cells and relative fluorescence intensities for M, 
F, and H bad decreased significantly by 48 or 72 h after 
treatment, the percentage of cells expressing N protein (in 
total 45%) was not changed at that time. After day 4, the 
number of N -expressing cells in the culture and the relative 
ftuorescence intensity was also drastically reduced. To mon-
itor the further disappearance of this protein, cells were 
harvested on days 6, 16, and 23 and analyzed for the 
expression of MV N protein by Western blot analysis, using 
a monoclonal anti-N antibody (Fig. 2a). Although N protein 
could still be detected after 6 days, the total amount of this 
proteinwas markedly reduced (Fig. 2a, lane 2). After 16 and 
23 days of treatment, no N protein synthesis could be 
detected (Fig. 2a, lanes 3 and 4). The down regulation ofMV 
structural proteins by anti-MV antiborlies seems to be spe-
cific since treatment with a nonspecific polyclonal rabbit 
antiserum for the same time period bad no effect (Fig. 2b). 
Upon removal of the antiborlies and analysis after 14 days, N 
protein was reexpressed (Fig. 2a, lane 5). Thus, modulation 
of MV protein synthesis in PI cells is reversible and depends 
on the presence of MV -specific antibodies. No inftuence on 
intracellular MV protein expression could be observed with 
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Car Lu cells when neutralizing anti-H antiborlies or anti-MV 
hyperimmune serumwas userl (not shown). 
Regulation of MV-specific transcription in antibody-treated 
NSZOY/MS cells. To test for the biologic activity of MV-
specific mRNAs in antibody-treaterl cells, in vitro translation 
experiments with poly(A)+ RNA from NS20Y/MS, C6/ 
SSPE, anrl Car Lu cells obtainerl 72 h after antiborly treat-
T ABLE 1. Relative expression frequencies of the monocistronic 
MV-specific transcripts in lytically infected Vero, NS20Y/MS, 
and C6/SSPE cells and in brain material of an experimentally 
infected Lewis rat (39)0 
Expression frequency (% 'f 
MV gene 
Vero/CAM NS20Y/MS C6/SSPE Lewis/AEc 
N 100 100 100 100 
p 82 52.4 48 47 
M 67.5 26 22 33 
F 46 10 9 15 
H 33 5.5 10 7 
"Signals specific for the monocistronic MV-specific transcripts in lytically 
infected Vero cells (Fig. la) and NS20Y/MS (Fig. lb), and C6/SSPE cells (Fig. 
lc) and for the Standard RNA transcripts were excised, and the retained 
radioactivity was determined by scintillation counting. 
b Expression frequencies for the individual transcripts were calculated 
relative to the N mRNA expression. 
c Brain material from a Lewis rat with acute MV encephalitis. 
FIG. 1. Transcription of MV-specific monocistronic mRNAs in 
lytically infected Vero cells and NS20Y/MS and C6/SSPE cells PI 
with MV. Northern blot analysiswas performed with poly(A)+ RNA 
isolated from 1 IJ.g of lytically infected Vero cells (a), 2 IJ.g of PI 
NS20Y/MS cells (b), and 1 IJ.g of C6/SSPE cells (c), as described 
previously (39). The application of a mixture of synthetic standard 
RNA transcripts (open arrowheads) to each RNA sample allowed 
the quantification of the signals obtained for the monocistronic 
MV-specific RNAs (filled arrowheads) per 10 pg of total RNA (12). 
Higher-migrating transcripts represent polycistronic MV -specific 
RNAs. (d) Fortherelative frequencies, the expressionrate for each 
individual mRNA downstream of the N gene was determined in 
relation to the Ievel of the N-specific transcript (Table 1). For 
comparison, the quantitative analysis of poly(A)+ RNA isolated 
from an experimentally MV -infected Lewis rat with acute enceph-
alitis (Lewis/AE) has been included (39). 
ment were performerl. For these experiments, a mixture of 
neutralizing anti-H antiborlies was userl, since it has been 
shown before that these antiborlies morlulate as efficiently as 
complete antiserum (4, 24). Corresponrling to the rlata ob-
tainerl in vivo, antiborly treatment revealerl only a slight 
effect on MV -specific protein expression in vitro in Car Lu 
cells (Fig. 3, lanes 2 anrl 3), whereas in NS20Y/MS (not 
shown) anrl C6/SSPE cells a significant rerluction of MV-
specific protein synthesis coulrl be observerl compared with 
that for the untreaterl control (C6/SSPE; Fig. 3, lanes 4 anrl 
5). The rlifferences in the electrophoretic mobilities of MV N 
anrl P proteins between lytic anrl persistent infections have 
been rlescriberl earlier (Fig. 3, lanes 1, 4, anrl 5) (35). 
T ABLE 2. Expression of MV structural proteins in antibody-
treated NS20Y /MS cellsa 
Treatment 
MV structural protein expressionb 
N M F H 
Untreated +++ +++ +++ +++ 
Day 1 +++ +++ +++ + 
Day2 +++ ++ + (+) 
Day3 ++ + + (+) 
Day4 ++ + (+) (+) 
Day 5 + (+) (+) ND 
Day6 + (+) ND ND 
" Cells were incubated with a polyclonal rabbit anti-MV hyperimmune 
serum for the intervals indicated, harvested, fixed, and analyzed for the 
expression of MV N, M, F, and H proteins by immunoftuorescence, using 
monoclonal antibodies. 
b + + +, strong; + +, intermediate; +, low; and ( + ), very low relative 
ftuorescence intensities. ND, not detectable. 
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FIG. 2. Modulation of MV protein polyclonal MV 
antiserum. NS20Y /MS cells were cultured in the presence of rabbit 
polyclonal MV antiserum (a) or nonspecific rabbit antibodies (b), 
and extracts were prepared and Western blot analysis was per-
formed by using a monoclonal mouse anti-N antibody (a) and a 
polyclonal anti-MV antiserum (b). Lanes: 1, untreated NS20Y/MS 
cells; 2, 6 days after antibody treatment; 3, 16 days after treatment; 
4, 23 days after antibody treatment; 5, 23 days after antibody 
treatment plus 14 days without antibodies. 
In order to determine the basis of the down regulation of 
MV -specific structural protein synthesis after treatment with 
antiborlies in vivo andin vitro, poly(A)+ RNA was isolated 
from antibody-treated and untreated NS20Y /MS cells at 
different time points and subjected to quantitative Northem 
blot analysis. To determine the immediate effects on MV 
transcription, we decided to choose early time points (12 to 
72 h after antibody treatment) for our analysis. Whereas at 
12 h after treatment no effect on MV transcription could be 
observed (Fig. 4a; Table 3), total transcription of MV-
specific monocistronic mRNAs as measured by the expres-
sion of the N-specific mRNA was attenuated significantly to 
19 and 10% after 24, 48, and 72 h, respectively (Fig. 4b and 
2 3 4 5 
FIG. 3. In vitro translation of poly(A)+ RNA from antibody-
treated and untreated C6/SSPE and Car Lu cells. Each 1 ~g of 
poly(A)+ RNA from lytically infected Vero cells (lane 1), Car Lu 
cells (lane 2), Car Lu cells treated with antibodies for 3 weeks (lane 
3), C6/SSPE cells (lane 4), and C6/SSPE cells treated with antibod-
ies for 72 h (lane 5) was translated in vitro and immunoprecipitated 
with anti-MV hyperimmune serum. Sampies were separated on 10% 
polyacrylamide gels. 
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FIG. 4. Expression of monocistronic MV-specific mRNAs in 
antibody-treated NS20Y/MS cells. Northem blot analysis of each 2 
~g of poly(A)+ RNA isolated from NS20Y/MS cells incubated with 
a mixture of virus-neutralizing monoclonal anti-H antibodies for 12 
(a), 48 (b), 72 (c), and 144 h after antibody removal from cells treated 
previously with antibodies for 144 h (d). Signals corresponding to 
the monocistronic MV-specific transcripts are indicated by filled 
arrowheads, and those for the standard RNA transcripts are indi-
cated by open arrowheads. 
c; Fig. 5a; Table 3), compared with that of the untreated 
control. Again, the M-specific probe hybridized with two 
M-specific poly(A)+ transcripts migrating at approximately 
the same rate (Fig. 4a to c, lanes 3). After removal of the 
antiborlies 6 days after treatment, transcription could be 
completely restored within 144 h (Fig. 4d). Control hybrid-
izations using a rat GAPDH cDNA were performed to 
confirm that equal amounts of poly(At RNA bad been 
analyzed (not shown). The quantitative analysis for the first 
three genes, N, P, and M, revealed no obvious diflerences in 
their relative expression frequencies in antibody-treated 
cells compared with those of the untreated controls (Fig. lb; 
Fig. 5b; Table 3). Quantification of the signals obtained for 
the monocistronic RNAs downstream of the N gene, in 
particular for envelope gene-specific mRNAs, was not pos-
sible due to their low frequencies (Fig. 4b and c). The same 
results were obtained with C6/SSPE cells ( as exemplified in 
Fig. 6b ). These data suggest that antibody-dependent restric-
tion of MV -specific protein expression in neural cells is 
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T ABLE 3. Quantitative analysis of MV gene transcription in 
antibody-treated NS20Y/MS cells (Fig. 4a to c) 
and untreated controls (Fig. 1b)" 
Frequency Expression frequency after indicated hours of 
for antibody treatment 
MV untreated 
gene controlb 12 24 48 72 
c/c % c/c % c/c % c/c % c/c % 
N 1,020 100 998 100 196 100 116 100 98 100 
p 680 66 665 67 102 52 78 67 67 68 
M 490 48 490 49 90 46 67 57 30 31 
F 155 15 160 16 NVC NV NV 
H 100 9 86 9 NV NV NV 
"Signals obtained for the monocistronic MV-specific transcripts in un-
treated and antibody-treated NS20Y /MS cells were excised, and the retained 
radioactivity was determined. 
b Expression frequencies for MV-specific mRNAs were expressed as copies 
per 10 pg of RNA and as relative values in relation to N-gene expression. 
c NV, not visible. 
based on a rapid transcriptional down regulation of all 
virus-specific mRNAs. 
Synthesis of MV -specific genomic RNA is down regulated in 
the presence of virus-neutralizing antibodies. The influence of 
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FIG. 5. Quantitative analysis of MV transcription in antibody-
treated NS20Y /MS cells. Signals obtained for the monocistronic 
MV -specific transcripts and for their corresponding standard RNA 
transcripts were excised from the Northern blots shown in Fig. 3 
and are shown as copy numbers per 10 pg of RNA (a) or as relative 
expression frequencies in relation to N gene expression (b). 
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FIG. 6. Northern blot analysis of total RNA from NS20Y /MS, 
C6/SSPE, and uninfected NS20Y cells treated or untreated with 
antibodies. Each 15 ~g of total RNA was separated on an agarose 
gel, blotted onto nitrocellulose, and hybridized to an N-specific 
[l2P]dCTP-labelled DNA probe. The signal intensities were deter-
mined by scanning densitometry of the autoradiograph. (a) 
NS20Y/MS cells untreated (lane 1), treated with antibodies for 12 h 
(lane 2), 24 h (lane 3), 48 h (lane 4), 72 h (lane 5), 144 h (lane 6), and 
196 h (lane 7) and uninfected NS20Y cells (lane 8). (b) C6/SSPE cells 
untreated (lane 1) and treated with antibodies for 144 h (lane 2). 
virus-neutralizing antibodies on the expression of MV -spe-
cific bicistronic and genomic RNA was assayed by Northem 
blot analysis of total RNA isolated from antibody-treated 
cells. Total cellular RNAs were separated and hybridized to 
an N-specific DNA probe, and MV-specific signals were 
analyzed by scanning densitometry. As determined earlier 
for NS20Y/MS cells (Fig. 4a to c), the relative frequency of 
the monocistronic N gene-specific transcripts appeared sta-
ble at 12 h after treatment and decreased about fivefold after 
24 h (Fig. 6a, lanes 1 to 7; Table 3). The intermediate-sized 
bicistronic NP transcript disappeared with approximately 
the same time kinetics (Fig. 6a, lanes 1 to 7; Table 3). Signals 
specific for the genomic RNA appeared to migrate as double 
bands, probably reflecting the incompletely denaluring gel 
system (Fig. 6a, lanes 1 to 7), and could not be detected in 
RNA isolated from uninfected NS20Y cells (Fig. 6a, lane 8). 
Since both bands appeared to be specific for the viral 
genome, the quantitativeanalysiswas performed by adding 
up both signal intensities (Table 4). Genomic RNA was 
expressed at a frequency of 9% of the monocistronic N -spe-
cific transcript in untreated NS20Y/MS cells. After treat-
ment with antibodies, the expression of the genomic RNA 
appeared to be approximately stable for 72 h (Fig. 6a, lanes 
1 to 4), whereas the relative frequency of the monocistronic 
transcripts decreased earlier (Fig. 6a, lanes 1 to 5; Table 4). 
With Ionger treatment, however, the signal intensity for the 
genomic transcript decreased to almost undetectable Ievels 
as described for the monocistronic transcript (Fig. 6a, lanes 
6 and 7). Similar results could be obtained with C6/SSPE 
cells treated with antibodies for 144 h (Fig. 6b, lane 2). 
DISCUSSION 
Persistent MV infection in cells of the central nervous 
system has been studied in detail at the molecular Ievel, 
providing experimental evidence for sequence alterations of 
the viral genome that inhibit or impair the expression of viral 
structural proteins (6). However, little is known about the 
mechanisms underlying the establishment of a persistent 
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T ABLE 4. Quantitative analysis of the expression of genomic, 
bicistronic, and monocistronic NS20Y /MS cells" 
Time (h) of Expression(%) of indicated Ratio of expression 
antibody N-specific transcript of monocistronic/ 
treatment Genomic Bicistronic Monocistronic genomic transcripts 
0 100 100 100 11:1 
12 93 100 100 11:1 
24 100 80 38 4:1 
48 72 27 22 3.5:1 
72 51 10 23 7:1 
96 19 NVb 11 7:1 
144 (3.5)c NV NV 
" Signal intensities for the genomic, bicistronic, and monocistronic N-spe-
cific transcripts shown in Fig. 6 were determined by scanning densitometry 
and expressed as percent of the untreated control (each 100% for the genomic, 
the bicistronic, and the monocistronic transcript). 
b NV, not clearly visible. 
c Value in parentheses was too low to be discerned clearly from the 
background. 
infection in neural cells anrl what mechanisms support this 
particular virus-host interaction besirles the action of cell-
type-specific factors (39, 40). 
Viral antiborlies have been shown to modulate virus-
induced disease processes in a variety of systems, including 
MV infections (1, 9, 23, 24, 33). In this context, a pathogenic 
roJe has been discussed earlier for virus-neutralizing anti-
hodies that are present in extremely high amounts in serum 
and cerebraspinal fluid of patients with SSPE (17, 18). 
Although the H protein is only expressed in trace amounts in 
brain material of patients with SSPE, sequence analyses 
have revealed that the corresponrling gene, in contrast to 
most of the other open rearling frames of MV genes, is highly 
conserved (6, 7). Therefore, it seems as if there are no 
structural or functional changes in this particular protein. 
To study the effect of antibody-induced antigenic modu-
lation on MV gene expression, we investigated MV-specific 
RNA expression in mouse neuroblastoma NS20Y /MS and 
C6/SSPE cells PI with MV. lt has been shown previously 
that nonneutralizing antiborlies rlirecterl against the N, M, F, 
and H proteins rlo not exert any modulating effects in tissue 
culture or in in vivo experiments (4, 24). Therefore, in part of 
our study, a mixture of three neutralizing anti-H antibodies 
was used. Either of the antibodies chosen alone has been 
shown to modulate MV gene expression in tissue culture and 
in vivo (4, 24). Confirming the results obtained with C6/ 
SSPE cells, a significant reduction in the expression of all 
MV structural proteins upon antibody treatment was ob-
served within a few days; that expression could be reacti-
vaterl completely after removal of the antibodies (Fig. 2a) 
(4). This particular effect proved to be specific for persis-
tently MV -infected cells of neural origin since infected lung 
fibroblasts did not show the antibody-dependent down reg-
ulation of MV protein synthesis (not shown). In addition, 
this effect appeared to be specific for MV antibodies (Fig. 
2b). 
The transcription pattem observed in the PI NS20Y /MS 
and C6/SSPE cells revealed restrictions of, in particular, the 
envelope gene-specific mRNAs identical to those observed 
in brain material of patients with SSPE and in experimentally 
infected rats (11, 12, 39) (Fig. 1b to d). This particular 
transcriptional regulation has not been described in PI cell 
lines of nonneural origin (11, 12) and may reftect a prereq-
uisite for MV persistence in brain cells. 
The analysis of MV -specific gene expression in antibody-
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treated NS20Y/MS cells revealed that down regulation of 
MV -specific transcription, as monitored by the expression of 
the N-specific mRNA, occurs as early as 24 h after applica-
tion of neutralizing antibodies to the tissue cultur'e (Fig. 3). A 
complete restoration of transcription was observed by 144 h 
after removal of the antibodies. This increase in transcrip-
tion most likely represents an activation of the viral genomes 
still present in the majority of cells rather than a clonal 
expansion. Barrett and coworkers (4) could show by single-
cell cloning of antibody-treaterl, MV protein-negative C6/ 
SSPE cells that MV expression could be reactivated after 
antibody removal in about 60% of all clones. In addition, in 
situ hybridization experiments performed on brain material 
of antibody-treated experimentally MV -infected Lewis rats 
revealed that, although a generat down regulation of viral 
protein and RNA synthesis was obvious, the total number of 
cells containing MV -specific RNA was not significantly 
reduced (24). 
In contrast to the results on down regulation of transcrip-
tion in newbom experimentally infected Lewis rats with 
passive transfer of antibodies (24), we could not find an 
impact of the antibodies on the slope of the transcription 
gradient in our tissue culture experiments (Fig. 3 and 4). This 
discrepancy may be due to the fact that the experiments 
performed in vivo definitely reftect a more complex experi-
mental system than our tissue culture experiment. We could, 
however, confirm that MV transcription is generally re-
stricted by 80%, as monitored by expression of the N-spe-
cific mRNA (Table 3). Although the decrease of mono- and 
bicistronic N -specific transcripts seems to occur after 24 h, 
expression of the genomic RNA is down regulated later than 
72 h after antibody treatment (Fig. 6, lanes 5 to 7). The data 
obtained in our study are consistent with the model that 
initiation of the polymerase complex for transcription anrl 
replication occurs at one polymerase entry site (20) and that 
replication of the viral genome is rlependent on de novo 
synthesis of viral protein synthesis (6). Since we found a 
down regulation of MV-specific RNA and protein synthesis, 
it is likely that replication of the viral genome has to be 
affected. Moreover, it has been described recently that 
defective nonreplicating MV particles reveal a maximum 
intracellular stability of 3 days (26), so that in the absence of 
transcription of monocistronic mRNAs a persistent infection 
could not be maintained. 
Experimental evidence for the inactivation of polymerase 
function after treatment with neutralizing antibodies has 
been obtained for inftuenza virus in vitro (31). Since the 
generat transcription pattem of MV did not seem to be 
affected, our interpretation of the data suggests that the 
regulation providerl by antibody-induced antigenic morlula-
tion is directed at the interaction between the polymerase 
complex and the promoter region of MV. Until now, the 
function of cis-acting sequences anrl their interaction with 
viral and/or cellular proteins could not be arlrlressed exper-
imentally. Recently, experiments have been designerl anrl 
successfully applied for analyzing those particular problems 
(15, 27, 30). Since those systems, however, depend on the 
functional expression of the viral polymerase complex, their 
application to the mechanisms of antibody-induced antigenic 
modulation appears difficult. 
1t remains unknown how an extemal signal provided by 
the neutralizing anti-H antibodies is transmitted and Ieads to 
the regulation of MV transcription. Experimental evirlence 
for a function of MV H protein as a signal-transrlucing 
receptor on C6/SSPE cells has been obtained by Weinmann-
Dorsch and Kosehel (43). After binding of neutralizing 
5540 SCHNEIDER-SCHAULIES ET AL. 
anti-H antibodies, an increase in phosphoinositide break-
down followed by elevated Ievels of 1,2-diacylglycerol and 
inositol triphosphate could be measured. These substances 
act as second messengers in the activation of protein kinase 
C and the release of Ca2 + from intracellular stores. Whether 
this activation takes part in the intracellular down regulation 
of MV transcription remains speculative, since it became 
evident recently that an increase in intracellular Ca2+ and 
the activation of protein kinase C up regulates MV transcrip-
tion in lytically MV -infected peripheral blood lymphocytes 
( 42). It remains to be investigated whether the latter findings 
obtained with a different cell type from a lytic infection also 
hold true for PI neural cells. Cellular protein kinases are 
likely to contribute to the activity of the viral polymerase 
complex since at least N and P proteins have been shown to 
be phosphorylated (36). As shown for vesicular stomatitis 
virus, phosphorylation of the P protein seems to be essential 
for its transactivating capacity and is, in part, dependent on 
the action of cellular kinases (3). 
Detailed analyses of the modifications and functions of the 
MV polymerase complex will be performed in order to 
understand its regulation by endogenous and exogenous 
factors present in cells of the centrat nervous system that 
enable the establishment and maintenance of persistent 
rather than ·lytic infections. 
ACKNOWLEDGMENTS 
We thank K. Kosehel for providing the C6/SSPE cell line; J. 
Schneider-Schaulies, K. Baczko, N. lsakov, and S. Segal for helpful 
discussions; Jeanette Roller, Marion Bayer, and Susanne Hellmig 
for excellent technical assistance; and Lee Dunster for correction of 
the manuscript. 
This work was supported by the Deutsche Forschungsgemein-
schaft and the Chief Scientist Office, Ministry of Health and the 
Institute of Psychobiology, Israel. 
REFERENCES 
1. AJexandersen, S., S. Larsen, A. Cohn, A. Uttentbat, R. E. Race, 
B. Aastedt, M. Hansen, and M. E. Btoom. 1989. Passive transfer 
of antiviral antibodies restricts replication of Aleutian mink 
disease parvovirus in vivo. J. Virol. 63:9-17. 
2. Baczko, K., U. G. Liebert, R. Cattaneo, M. A. Billeter, R. P. 
Roos, and V. ter Meuten.1988. Restrietion of measles virus gene 
expression in measles virus inclusion body encephalitis. J. 
lnfect. Dis. 158:144-150. 
3. Banerjee, A. K. 1987. Transcription and replication of rhabdo-
viruses. Microbiol. Rev. 51:66-87. 
4. Barrett, P. N., K. Koscbet, M. Carter, and V. ter Meulen. 1985. 
Effect of measles virus antibodies on a measles SSPE virus 
persistently infected C6 rat glioma cell line. J. Gen. Virol. 
66:1411-1421. 
5. Bass, B. L., H. Weintraub, R. Cattaneo, and M. A. Billeter. 
1989. Biased hypermutation of viral genomes could be due to 
unwindinglmodification of double stranded RNA. Cell56:331. 
6. Billeter, M. A., and R. Cattaneo. 1991. Molecular biology of 
defective measles viruses persisting in the human central ner-
vaus system, p. 323-345. In D. Kingsbury (ed.), The para-
myxoviruses. Plenum Press, New York. 
7. Billeter, M. A., R. Cattaneo, A. Scbmid, D. Escbte, K. Kälin, G. 
Rebmann, S. A. Udem, R. D. Sbeppard, K. Baczko, U. G. 
Liebert, S. Scbneider-Scbaulies, U. Brinckmann, and V. ter 
Meuten. 1989. Host and viral features in persistent measles virus 
infections of the brain, p. 35~366. In D. Kolakofsky and 
B. W. J. Mahy (ed.), Genetics and pathogenicity of negative 
strand viruses. Elsevier Biomedical Press, Amsterdam. 
8. Birrer, M. J., B. R. Bloom, and S. A. Udem. 1981. Characteri-
zation of measles virus polypeptides by monoclonal antibodies. 
Virology 108:381-390. 
9. Bucbmeier, M. J., H. A. Lewicki, P. J. Talbot, and R. L. 
J. VIROL. 
Knobter. 1984. Murine hepatitis virus 4 (strain JHM) induced 
neurologic disease is modulated in vivo by monoclonal antibod-
ies. Virology 132:261-270. 
10. Carter, M., M. M. Willcocks, S. Löftler, and V. ter Meulen. 
1983. Relationships between monoclonal antibody binding sites 
on the measles virus hemagglutinin. J. Gen. Virol. 63:113-120. 
11. Cattaneo, R., G. Rebmann, K. Baczko, V. ter Meuten, and M. A. 
Billeter. 1987. Altered ratios of measles virus transcripts in 
diseased human brains. Virology 160:523-526. 
12. Cattaneo, R., G. Rebmann, A. Schmid, K. Baczko, V. ter 
Meulen, and M. A. Billeter. 1987. Altered transcription of a 
defective measles virus genome derived from a diseased human 
brain. EMBO J. ':681-687. 
13. Cattaneo, R., A. Scbmid, K. Baczko, V. ter Meulen, S. A. Udem, 
and M. A. Billeter. 1989. Pronounced transcription attenuation 
and mutations cause defective measles virus gene expression in 
diseased human brains, p. 425-434. In R. W. Campans (ed.), 
Cell biology of virus entry, replication and pathogenesis. Alan 
R. Liss, Inc., New York. 
14. Cattaneo, R., A. Scbmid, D. Escble, K. Baczko, V. ter Meulen, 
and M. A. Billeter. 1988. Biased hypermutation and other 
genetic changes in defective measles viruses in human brain 
infections. Cell 55:255-265. 
15. Collins, P. L., M. A. Mink, and D. S. Stec. 1991. Rescue of 
synthetic analogues of respiratory syncytial virus genomic RNA 
and effect of truncations and mutations on the expression of a 
foreign reporter gene. Proc. Natl. Acad. Sei. USA 88:9663-
9667. 
16. Fort, P., L. Marty, M. Piecbaczyk, S. Elsatrouty, C. Dani, P. 
Janteur, and J. M. Blancbard. 1985. Various rat adult tissues 
express only one major mRNA species from the glyceralde-
hyde-3-phosphate dehydrogenase family. Nucleic Acids Res. 
13:1431-1442. 
17. Fl\iinami, R. S., and M. B. A. Oldstone. 1919. Antiviral antibody 
reacting on the plasma membrane alters measles virus expres-
sion inside the cell. Nature (London) 279:529-530. 
18. Fl\iinami, R. S., and M. B. A. Oldstone. 1980. Alterations in 
expression of measles virus polypeptides by antibody molecular 
events in antibody-induced antigenic modulation. J. Immunol. 
125:78-85. 
19. Halbacb, M., and K. Koscbel. 1979. Impairment of hormone 
dependent signal transfer by chronic SSPE virus infection. J. 
Gen. Virol. 42:615-619. 
20. Horikami, S. M., and S. A. Moyer. 1991. Synthesis of Ieader 
RNA and editing of the P mRNA during transcription by 
purified measles virus. J. Virol. 65:5342-5347. 
21. Ju, G., S. A. Udem, B. Rager·Zisman, and B. R. Bloom. 1978. 
Isolation of a heterogeneaus population of temperature sensitive 
mutants of virus from persistently infected human lymphoblas-
toid cells. J. Exp. Med. 147:1637-1652. 
22. Kobune, K., F. Kobune, K. Yamanouchi, K. Nagasbima, Y. 
Yosbikawa, and M. Hayami. 1983. Neurovirulence of rat brain 
adapted measles virus. Jpn. J. Exp. Med. 53:177-180. 
23. Levine, B., J. M. Hardwick, B. D. Trapp, T. 0. Crawford, R. C. 
Bollinger, and D. E. Grillin. 1991. Antibody-mediated clearance 
of alphavirus infection from neurons. Science 254:85~60. 
24. Liebert, U. G., S. Schneider-Scbaulies, K. Baczko, and V. ter 
Meuten. 1990. Antibody-induced restriction of viral gene 
expression in measles encephalitis in rats. J. Virol. 64:70~713. 
25. Miller, C. A., and D. R. Carrigan. 1982. Reversiblerepression 
and activation of measles virus infection in neural cells. Proc. 
Natl. Acad. Sei. USA 79:1629-1633. 
26. Mottet, G., J. Curran, and L. Roux. 1990. Intracellular stability 
of nonreplicating paramyxovirus nucleocapsids. Virology 176: 
1-7. 
27. Moyer, S. A., S. C. Baker, and S. M. Horikami. 1990. Host cell 
proteins required for measles virus reproduction. J. Gen. Virol. 
71:775-783. 
28. Norrby, E. 1967. A carrier cellline of measles virus in Lu 106 
cells. Arch. Gesamte Virusforsch. 20:215-224. 
29. Norrby, E., K. Kristensson, W. J. Brzosko, and J. G. Kapsen-
berg. 1985. Measles virus matrix protein detected by immune 
fluorescence with monoclonal antibodies in the brain of patients 
VOL. 66, 1992 
with subacute sclerosing panencephalitis. J. Virol. 56:337-340. 
30. Park, K. H., T. Huang, F. F. Correira, and M. Krystal. 1991. 
Rescue of a foreign gene by Sendai virus. Proc. Natl. Acad. Sei. 
USA 88:5537-5541. 
31. Possee, R. D., G. C. Schild, and N. J. Dimmoc:k. 1982. Studies on 
the mechanism of neutralization of inftuenza virus by antibody: 
evidence that neutralizing antibody (anti-hemagglutinin) inacti-
vates inftuenza virus in vivo by inhibiting virion transcriptase 
activity. J. Gen. Virol. 58:373-386. 
32. Rager-Zisman, B., J. E. Egan, Y. Kress, and B. R. Bloom. 1984. 
Isolation of cold-sensitive mutants of measles virus from per-
sistently infected murine neuroblastoma cells. J. Virol. 51:845-
855. 
33. Rammohan, K. W., H. F. McFarland, and D. E. McFarlin.1981. 
lnduction of subacute murine measles encephalitis by monoclo-
nal antibody to virus hemagglutinin. Nature (London) 290:588-
589. 
34. Rataul, S. M., A. Hirano, and T. C. Wong. 1992. Irreversible 
modification of measles virus RNA in vitro by nuclear RNA-
unwinding activity in human neuroblastoma cells. J. Virol. 
66:1769-1773. 
35. Rima, B. K.1983. The proteins ofmorbilliviruses. J. Gen. Virol. 
64:1205-1219. 
36. Rima, B. K., S. A. Lappin, M. W. Roberts, and S. J. Martin. 
1981. A study of phosphorylation of the measles membrane 
protein. J. Gen. Virol. 56:447~50. 
MEASLES VIRUS TRANSCRIPTIONAL REGULATION 5541 
37. Robbins, S. J., and F. Rapp. 1980. Inhibition of measles virus 
replication by cyclic AMP. Virology 106:317-326. 
38. Rustigian, R. 1966. Persistent infection of cells in culture by 
measles virus. 1. Development and characteristics of HeLa 
sublines persistently infected with complete virus. J. Bacteriol. 
92:1792-1804. 
39. Schneider-Schaulies, S., V. G. Liebert, K. Baczko, R. Cattaneo, 
M. Billeter, and V. ter Meulen. 1989. Restrietion of measles 
virus gene expression in acute and subacute encephalitis of 
Lewis rats. Virology 171:525-534. 
40. Schneider-Schaulies, S., V. G. Uebert, K. Bac:zko, and V. ter 
Meulen. 1990. Restricted expression of measles virus in primary 
rat astroglial cells. Virol. 177:802-806. 
41. ter Meulen, V., J. R. Stephenson, and H. W. Kreth. 1983. 
Subacute sclerosing panencephalitis. Compr. Virol. 18:105-159. 
42. Vanionpää, R., T. Hyypiä, and K. E. Ackerman. 1991. Early 
signal transduction in measles virus-infected lymphocytes is 
unaltered, but second messengers activate virus replication. J. 
Virol. 65:6743-6748. 
43. Weinmann-Dorsc:h, C., and K. Kosc:hel. 1989. Coupling of viral 
membrane proteins to phosphatidylinositide signalling system. 
FEBS Lett. 247:185-188. 
44. Yoshikawa, Y., and K. Yamanoucbi. 1984. Effects of papaverine 
treatment on replication of measles virus in human neural and 
nonneural cells. J. Virol. 50:489-496. 
